Physician profile
Samir Patel
NPI 1659784973
$1,815.34
in general payments reported to CMS, 2019-2025
13 companies · $164 in 2025
The $164 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $138 · 2021: $340 · 2022: $750 · 2023: $50.88 · 2024: $244 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $692.80 | 2019-2024 | Spravato |
| Teva Pharmaceuticals USA, INC. | $363.04 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $256.62 | 2023-2025 | Airsupra, Breztri |
| Sunovion Pharmaceuticals INC. | $181.97 | 2020-2021 | |
| Alfasigma USA, INC. | $89.08 | 2022 | |
| Axsome Therapeutics, INC. | $76.04 | 2025 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $39.75 | 2022 | |
| Pfizer INC. | $34.28 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $20.23 | 2023 | Inpefa |
| La Jolla Pharmaceutical Company | $17.14 | 2022 | |
| Lilly USA, LLC | $15.97 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.45 | 2019 | |
| Eisai INC. | $13.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.